SUN PHARMACEUTICAL INDUSTRIES INC recalls Spironolactone Tablets
- Published
- 13 Aug 2025
- Units affected
- 11,328 bottles
- Agency
- FDA
- Country
- United States
The hazard
Presence of foreign substance: identified as aluminum.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01
- Brand / company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Codes / lots
- Lot # P3314, Exp 11/30/2026
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 13 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.